Is Liquidia Corporation (LQDA) Overvalued?
We dive into why Liquidia Corporation (LQDA) could be considered overvalued on 2026-07-24, based on AAII’s Value Score and Grade.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company’s lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Commentary & Analysis
Why Liquidia Corporation’s (LQDA) Stock Is Up 9.40%
As of Wednesday, July 22, Liquidia Corporation’s LQDA share price has surged by 9.40%, which has investors questioning if this is right time to sell.Michael Rose
Why Liquidia Corporation’s (LQDA) Stock Is Up 6.30%
As of Tuesday, July 14, Liquidia Corporation’s LQDA share price has surged by 6.30%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Liquidia Corporation’s (LQDA) Stock Is Down 6.24%
As of Monday, July 13, Liquidia Corporation’s LQDA share price has dipped by 6.24%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Liquidia Corporation’s (LQDA) Stock Is Down 6.41%
As of Friday, July 10, Liquidia Corporation’s LQDA share price has dipped by 6.41%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | LQDA | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7,479.7 | $579.1 | 73% |
|
| Shares Out (Mil) | 101.1 | 43.0 | 63% |
|
| Institutional Ownership | 86.9% | 84.3% | 55% |
|
| Float (Mil) | 62.3 | 46.8 | 52% |
|
| Beta | 0.42 | 0.62 | 23% |
|
| Avg Daily Volume (000s) | 1,511 | 285 | 77% |
|
| Price Change (52-week) |
340.1% | 63.8% | 99% |
|
| Growth | LQDA | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 195.7% | 6.7% | 100% |
|
| Net Income (5yr) | (2.9%) | (1.4%) | 36% |
|
| EPS (5yr) | 14.6% | 14.9% | 55 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (5.6%) | (14.9%) | 61% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 5 | 5 | |
| Current EPS | $0.836 | $3.480 | $5.808 | |
| Month Ago EPS | $0.836 | $3.480 | $5.572 | |
| # Rev Up | 1 | 2 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | $0.530 | $2.578 | $5.238 | |
| Year/Year Chg | 60.8% | (534.5%) | (906.0%) | |
| Financials | LQDA | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $288 | $272 | 36% |
|
| Net Income (TTM) (Mil) | $22 | ($11) | 50% |
|
| EPS (TTM) | $0.257 | ($0.500) | 49% |
|
| Operating Cash Flow (TTM) (Mil) | $48 | ($6) | 47% |
|
| Net Cash Flow (TTM) (Mil) | $57 | $4 | 72% |
|
| Long-Term Debt (Q1) (Mil) | $134 | $7 | 46% |
|
| Enterprise Value (Q1) (Mil) | $4,687 | $522 | 62% |
|
| Valuation | LQDA | Industry Median |
Percentile (All Stocks) |
|
| P/B | 68.38 | 2.73 | 99% |
|
| P/E | 344.7 | 20.5 | 99% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 23.6 | 1.2 | 98% |
|
| Ratios | LQDA | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 91.8% | 65.9% | 94% |
|
| Net Margin | 7.7% | 0.7% | 57% |
|
| ROA | 7.1% | (24.6%) | 80% |
|
| ROE | 28.2% | (19.7%) | 87% |
|
| Liabilities to Assets | 73.0% | 35.5% | 68% |
|
| F-Score | 6 | 3 | 69% |
|
Liquidia Corporation did not pass any screens on 7/31/2026.
